Liquid Dosage
Insulin
With diabetes on the rise and the global insulin market estimated to be worth more than $32 billion by 2018, demand for GEA technologies for the production of this life-saving drug is already high and set to increase, particularly in new markets and emerging economies.
State-of-the-Art Solutions
GEA produces and supplies process systems for the production of liquid products for the pharmaceutical and biotechnological industries, and has a proven history of successfully installing plant for the production of insulin, including the engineering, delivery, commissioning and qualification of entire ultra-pure media systems as well as various process equipment and cleaning installations.
A worldwide technology leader in insulin production, GEA is able to supply the clean utility systems and manage the integration of all the main processes, including fermentation, harvesting, chromatography, filtration and freeze drying.
From Fermentation to Freeze Drying
The biosynthetic production of human insulin is done using bacteria or yeast cells. Following fermentation, or the conversion of chemical raw materials by micro-organisms, the biomass is extracted using a nozzle separator, washed, concentrated and finally precipitated to produce insulin crystals.
Centrifuges and process lines provided by GEA have an established pedigree in the clarification, separation, classification, concentration and fractionation steps. Nozzle separators also play an important part in the production process. Further, GEA chamber or self-cleaning separators can be used in the subsequent crystallization stages.
GEA is a single-source supplier of a variety of fermenters, media preparation, buffer storage, harvesting and cell rupture solutions, equipment for the purification and isolation of cells, separation (after both first and final crystallization), the production and distribution of WFI, CIP and freeze drying technologies, all of which can be installed and integrated into a state-of-the-art insulin production facility.
المنتجات والتقنيات
يتم عرض 4 من 14
Lyophilizers (Pharma Freeze Dryers)
GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.
R&D Drying Systems
GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.
أنظمة التحميل/التفريغ
يُعد التصميم والتطوير وإنتاج نظم التحميل والتفريغ للاستخدامات في العديد من الصناعات هو الأختصاص الأساسي لمجموعة GEA. ومهما كان المنتج أو العملية، فإن الحلول القياسية أو المصممة حسب الحاجة، سواء كانت تعمل يدويًا أو مؤتمتة بالكامل، يمكن بناؤها وتسليمها لتلبية الاحتياجات الفردية لعملائنا.
الصمامات والمكونات للمعالجة السائلة المعقمة
تواجه صمامات التعقيم مطالب عالية بشكل استثنائي داخل العمليات فائقة النظافة وعمليات التعقيم. وبما أن سلامة المنتج والعملية تحظى بأولوية قصوى ضمن هذه التطبيقات، فقد تم تجهيز صماماتنا بعنصر ختم محكم لتجنب دخول الكائنات الحية الدقيقة إلى عملية معقمة. ومع ثلاث خطوط من الصمامات المختلفة، نقدم المكون المثالي لجميع أنواع التطبيقات والتفضيلات الشخصية. يمك...
Downloads
رؤى GEA
All pharmaceutical freeze-drying vials are the same! Aren't they?
Whether it’s a fad or the future, 100% vial traceability is becoming an increasingly important consideration in the pharmaceutical freeze drying industry. Keeping a close eye on developments is GEA. We’re investigating possible solutions and, what’s more, we have the experience, expertise and know-how to implement them.
البيرة الخالية من الكحول: إنهم يريدون كل شيء - إنهم يريدون أقل
كان هناك وقت حيث من النادر استخدام عبارتي "بيرة خالية من الكحول" و "طعمها جيد" معًا في الجملة نفسها، خاصة من قبل المستهلكين. ولكن قطعت البيرة منخفضة الكحول والبيرة الخالية من الكحول شوطًا طويلًا - وأصبح الكثير منها الآن مشروبات منعشة في حد ذاتها - بفضل جزء صغير من تكنولوجيا GEA.
Innovating patient care with aseptic spray drying
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.
